NEW YORK, Nov. 24, 2016 /PRNewswire/ -- The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2021. Influenza is a highly communicable disease and typically has the most severe impact on children and the elderly. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.
Geographically, North America is the largest market for influenza vaccines capturing around 50% market share in 2015. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2015. Australasia accounted for least share of the influenza vaccines market in 2015.
On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines with around XX% share in 2015. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2015. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.
In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. FluMist/Fluenz and Afluria/Fluvax stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.
This is the 2nd edition report on influenza vaccines market by iGATE Research. The report titled "Global Influenza Vaccines Market and Forecast to 2021 - Size, Share, Growth and Trends Analysis" provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 195 Page report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market landscape.
The Influenza Vaccines Market have been analyzed from 5 viewpoints:
1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2021)
2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2021)
3. Global - Influenza Vaccines Brand Sales and Forecast to 2021
4. Global Influenza Vaccines Market - Major Deals
5. Global Influenza Vaccines Market - Driving Factors and Challenges
Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region
1. North America
2. Latin America
Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)
1. United States
9. United Kingdom
16. New Zealand
20. South Korea
22. Hong Kong
Global Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed
Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases
Read the full report: http://www.reportlinker.com/p04387760-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: firstname.lastname@example.org
Intl: +1 339-368-6001
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-influenza-vaccines-market-and-forecast-to-2021---size-share-growth-and-trends-analysis-300368573.html